about
Cardiovascular Autonomic Neuropathy Is an Independent Risk Factor for Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome.Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysisHepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high-fat diet-fed mice.Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial.Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat DietComparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48-week, multiActive surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidenceModulation of gut microbiota contributes to effects of intensive insulin therapy on intestinal morphological alteration in high-fat-diet-treated miceInfluence of fetal sex on perinatal outcomes in women with gestational diabetes mellitusMetabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetesNocturnal ventricular arrhythmias are associated with the severity of cardiovascular autonomic neuropathy in type 2 diabetesImproved skeletal muscle energy metabolism relates to the recovery of β cell function by intensive insulin therapy in drug naïve type 2 diabetesOlfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies
P50
Q33790560-A05D0DDF-6846-436F-BDE4-C2C952C09711Q53690282-413535CE-D646-47F9-99D5-1BCC618D3C49Q58732753-13C05FA4-F183-4E29-83B2-DC0D03B07B8FQ64911607-5DB435DD-A838-46E4-96B2-03A50DE8EE2DQ64931965-66A2A6DE-1387-4AAF-966B-BC06E44416D8Q90152137-ACF6AA5C-C810-4C79-88ED-24EE2487F3C4Q90297993-909B8D47-5944-4EED-95DC-B2680DAA5F1AQ90392003-63D9ACDF-6C04-4BA4-A5F9-AC4C20F08D66Q91363918-6D916FD0-F6BF-4CB7-B88B-6F29A51ACF5CQ91407984-BBC11FAB-0C9F-4E68-A3B0-4CFB4CA5EBE9Q91445282-35B2809D-DC69-4944-8458-90345D163A34Q91609079-A70D7D43-2A82-48C0-AF11-79CA7D6DB4E4Q91939924-94C03B17-F7B3-4D4C-A6A5-1E68451FA280Q92916154-6DE46D23-81B7-496B-A5B9-5A1B808BB74D
P50
description
researcher (ORCID 0000-0003-3914-7854)
@en
wetenschapper
@nl
name
Yan Bi
@en
Yan Bi
@nl
type
label
Yan Bi
@en
Yan Bi
@nl
prefLabel
Yan Bi
@en
Yan Bi
@nl
P31
P496
0000-0003-3914-7854